The Annual Scientific Meeting for Leaders in Lung Health & Respiratory Science | 27 – 31 March 2026 | Perth Convention and Exhibition Centre

Sponsored Symposia

Please indicate your attendance at the Sponsored Symposia at the time of registration. If you are already registered for the ASM and wish to attend a sponsored symposia, or have any questions, contact us via email at tsanzsrs@theconferencecompany.com. 
If you have not yet registered for the ASM, you can register as part of the online registration form here.

Saturday, 28th March 2026

Sanofi Evening Symposia: ADVENT Symposium: 'Inflamed or Informed? The great biomarker debate'

Time: 5.45pm - 7.15pm (food served at 5.00pm)
Speakers: A/Prof Sanjay Ramakrishnan, Dr Clare Tiedeman, A/Prof Katrina Tonga, Prof Claude Farah 
Chair: Dr Mario Castro

Synopsis: Biomarkers promise precision — but do they deliver certainty?

This clinician-led debate examines the role of biomarkers in guiding treatment decisions
in asthma and COPD. Through expert discussion, case-based scenarios, and live audience polling, the session will explore the strengths, limitations, and real-world application of biomarker-driven approaches to managing asthma and COPD.

Chaired by international guest Dr Mario Castro, this session brings together expert perspectives to examine how biomarkers inform and sometimes challenge clinical judgment in everyday practice.

 

Sunday, 29th March 2026

AstraZeneca Breakfast Symposia: Early Lessons from Lung Cancer Screening Implementation

Time: 7.15am - 8.15am (breakfast served at 6.45am)
Speakers: Prof. Henry Marshall, Prof. Fraser Brims, Abby Fyfe
Chairs: Dr Tracy Leong and Dr Gerard Olive

Synopsis: 

• Welcome and Introduction - Dr Tracy Leong
• Recruitment Realities: Insights from Early Lung Cancer Screening Implementation - Associate Prof. Henry Marshall
• Detection is only the Start: System Capacity, Triage and Care Delivery - Prof Fraser Brims
• Applying Lessons to Symptomatic and Incidental Findings - Abby Fyfe
• Discussion - Dr Gerry Olive

Boehringer Ingelheim Breakfast Symposia: ILD Mortality Matters: A call for Early, Holistic Intervention

Time: 7.15am - 8.15am (breakfast served at 6.45am)
Speakers: Dr Nicole Goh, Prof Daniel Chambers, Prof Tamera Corte
Chair: Dr Nicole Goh

Synopsis: 

• What is the most meaningful outcome? What is most meaningful in the clinical development of new treatments? - Dr Nicole Goh
• Epidemiology and mortality trends in ILD. Overview of current endpoints in ILD clinical trials. What is most clinically important/relevant. - Prof Daniel Chambers
• Therapeutic advances and impact on survival - Prof Tamera Corte

 

Chiesi Breakfast Symposia: Small Airways: Big Impact: Integrating Oscillometry into Clinical Practice for Asthma and COPD

Time: 7.15am - 8.15am (breakfast served at 6.45am)
Speakers: Clinical Professor Claude Farah, Dr Li Ping Ching, Dr Sanjay Ramakrishnan
Chair: Clinical Professor John Blakey 

Synopsis: Small airways disease (SAD) is a critical yet often overlooked driver of poor outcomes in asthma and COPD. This symposium highlights the latest international consensus on oscillometry interpretation, real-world evidence from the SADWA Part 2 study linking oscillometric Z-scores to asthma control and exacerbation risk, and the MASCOT study, which evaluated the impact of targeting SAD with triple therapy on lung function and health status in COPD. Discover how integrating oscillometry into routine practice can transform the detection and management of small airways disease.

 

 

 

GSK Evening Symposia: Whats the T2 truth? Uncovering type-2 inflammation in COPD

Time: 6.00pm - 7.30pm (food served at 5.30pm)
Speakers: Professor Jadwiga Wedzicha, Dr sanjay Ramakrishnan and Professor Philip Bardin

Synopsis: This symposium will provide an in-depth exploration of type 2 inflammation in COPD, with a particular emphasis on the eosinophilic phenotype. The session will delve into the underlying cellular mechanisms, highlight the clinical features that distinguish eosinophilic COPD from asthma, and examine the practical implications for accurate diagnosis and tailored treatment strategies.

 

 

Monday, 30th March 2026

AstraZeneca Breakfast Symposia: Caring for people with COPD: Impact of Guideline-Directed Medical Therapy on people with COPD and the planet; reducing cardiopulmonary risk

Time: 7.15am - 8.15am (breakfast served at 6.45am)
Speakers: Prof Michael Crooks, Dr Sanjay Ramakrishnan
Chair: Prof Christine Jenkins

Synopsis: The symposium will explore how guideline-directed medical therapy (GDMT) can jointly benefit patients with COPD and the planet. As the climate crisis exacerbates respiratory disease and healthcare delivery contributes to greenhouse gas emissions, proactive COPD management to prevent exacerbations and reduce cardiopulmonary events emerges as both a clinical imperative and an environmental strategy. Evidence indicates that well-controlled disease reduces healthcare resource use and associated carbon emissions, making optimal control the most sustainable model of care.